[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658997":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":24,"studyPopulation":13,"armGroups":25,"interventions":45,"overallOfficials":13,"centralContacts":13,"locations":60,"responsibleParty":71,"collaborators":13,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":13,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":13,"enrollmentInfo":82,"targetDuration":13,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":13,"overallStatus":91,"whyStopped":13,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"GL Pharm Tech Corporation","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Change from Baseline in International Index of Erectile Function - Erectile Function (IIEF-EF) Domain Score","Change from baseline in the erectile function domain score assessed using the International Index of Erectile Function (IIEF) questionnaire.","Baseline, Week 12",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":20},"TRIPLE",[21,22,23],"PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR","The purpose of this study is to evaluate the efficacy and safety of W2505 in patients with erectile dysfunction.",[26,33,39],{"label":27,"type":28,"description":29,"interventionNames":30},"Experimental","EXPERIMENTAL","W2505 and W2505-P2, 12 weeks.",[31,32],"Drug: W2505","Drug: W2505-P2",{"label":34,"type":35,"description":36,"interventionNames":37},"Placebo Comparator","PLACEBO_COMPARATOR","W2505-P1 and W2505-P2, 12 weeks.",[38,32],"Drug: W2505-P1",{"label":40,"type":41,"description":42,"interventionNames":43},"Active Comparator","ACTIVE_COMPARATOR","W2505-P1 and W2505-R, 12 weeks.",[38,44],"Drug: W2505-R",[46,51,54,57],{"type":47,"name":48,"description":49,"armGroupLabels":50,"otherNames":13},"DRUG","W2505","PO, Once daily(QD), 12 weeks",[27],{"type":47,"name":52,"description":49,"armGroupLabels":53,"otherNames":13},"W2505-P1",[40,34],{"type":47,"name":55,"description":49,"armGroupLabels":56,"otherNames":13},"W2505-R",[40],{"type":47,"name":58,"description":49,"armGroupLabels":59,"otherNames":13},"W2505-P2",[27,34],[61],{"facility":62,"status":13,"city":63,"state":13,"zip":13,"country":64,"countryCode":13,"cosmosGeoPoint":65,"geoPoint":70,"contacts":13},"Inha University Hospital","Incheon","South Korea",{"type":66,"coordinates":67},"Point",[68,69],126.70515,37.45646,{"lat":69,"lon":68},{"type":72,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100658997","phase-3-the-purpose-of-this-study-is-to-evaluate-the-efficacy-and-safety-of-w2505-100658997",false,"NCT07859202","The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.","A Prospective, Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of W2505","Inclusion Criteria:\n\n* Male aged 19 years or older.\n* Capable of completing study diaries and questionnaires independently.\n* Signed written informed consent.\n* run-in medication compliance ≥ 70%\n\nExclusion Criteria:\n\n* Primary hypoactive sexual desire.\n* Erectile dysfunction caused by premature ejaculation or untreated endocrine disorders (e.g., untreated hypogonadism, hyperprolactinemia).\n* Other exclusions applied.","MALE","19 Years",{"count":83,"type":84},228,"ESTIMATED","INTERVENTIONAL",[87],"PHASE3","The purpose of this study is to evaluate the efficacy and safety of W2505.",[90],"Erectile Dysfunctions","NOT_YET_RECRUITING","2026-09-29",{"date":94,"type":95},"2026-10-05","ACTUAL",{"date":97,"type":84},"2026-09",{"date":99,"type":84},"2027-07",{"name":5,"class":6},1]